Broome Oncology

Latest Cancer News

3-Year Survival Improved with Taflinar®/Mekinist® Combination in Advanced Melanoma (07-21-2016)
Patients with advanced melanoma who were treated with the combination consisting of Taflinar (dabrafenib) plus Mekinist (trametinib) had a significantly improved survival rate at 3 years compared to those... Continue Reading

Loxo Oncology Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for LOXO-101 (07-19-2016)
Loxo Oncology, Inc. (LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, announced that the U.S. Food and Drug Administration... Continue Reading

FDA Places Hold on a Trial Evaluating Genetically Engineered Immune Cells for Cancer Treatment (07-18-2016)
The United States Food and Drug Administration (FDA) has placed a hold on a clinical trial, referred to as the ROCKET trial, due to side effects of the treatment that may be associated with 3 patient deaths. Chimeric... Continue Reading

More Cancer News

Locations

Binghamton
169 Riverside Drive
Binghamton, NY 13905
(607) 798-5307
Click here to visit the Lourdes website
Johnson City
30 Harrison Street
Johnson City, NY 13790
(607) 763-6850
Click here to visit the UHS website
Office Hours (both locations)
Monday – Thursday 8:00am – 4:30pm
Friday 8:00am- 12:00pm